tiprankstipranks
Trending News
More News >
Noumi Limited (AU:NOU)
ASX:NOU
Australian Market
Advertisement

Noumi Limited (NOU) AI Stock Analysis

Compare
2 Followers

Top Page

AU:NOU

Noumi Limited

(Sydney:NOU)

Rating:40Underperform
Price Target:
AU$0.00
▼(-100.00% Downside)
Noumi Limited's overall stock score is heavily impacted by its weak financial performance, which is the most significant factor. The bearish technical indicators and poor valuation further contribute to a low overall score. The lack of earnings call data and corporate events leaves the financial and technical aspects as the primary considerations.

Noumi Limited (NOU) vs. iShares MSCI Australia ETF (EWA)

Noumi Limited Business Overview & Revenue Model

Company Descriptionnoumi Limited engages in sourcing, manufacture, selling, marketing, and distribution of plant-based beverages, and dairy and nutritional ingredient products to wholesale and consumer markets. It operates in Dairy and Nutritional, and Plant Based Beverages segments. The company offers a range of ultra-heat treatment technology (UHT) shelf stable dairy milk beverage, nutritional products, and performance and adult nutritional powders. It also provides various UHT shelf stable food and beverage products, including almond, oat, soy, rice, coconut, hazelnut, and other nut-based beverages and liquid stocks. The company provides its products under the Milklab, Australia's Own, Crankt, Vital Strength, Noumi Nutritionals, Uproteinn, So Natural, and Vitalife brands. It operates in Australia, New Zealand, South Africa, China, South East Asia, and the Middle East. noumi Limited was formerly known as Freedom Foods Group Limited. The company was incorporated in 1984 and is headquartered in Ingleburn, Australia. noumi Limited is a subsidiary of Arrovest Pty Limited.
How the Company Makes MoneyNoumi Limited generates revenue through the sale of its diverse product lineup, which includes dairy and plant-based beverages, nutritional products, and specialty ingredients. The company's revenue streams are driven by the distribution of these products to supermarkets, grocery stores, and other retail outlets both in Australia and internationally. Noumi also benefits from strategic partnerships and alliances that enhance its market reach and distribution capabilities. Additionally, the company's focus on innovation in product development and expansion into emerging markets contributes to its financial performance.

Noumi Limited Financial Statement Overview

Summary
Noumi Limited exhibits a challenging financial profile with consistent net losses and negative equity over recent years. Although there is slight improvement in revenue and operating cash flow, the company faces significant leverage and solvency issues.
Income Statement
40
Negative
Noumi Limited's revenue has shown some growth, increasing from AUD 551.6 million in 2023 to AUD 589.8 million in 2024, representing a growth rate of 6.93%. However, the net profit margin remains negative due to consistent net losses, with a negative net income of AUD 98.3 million in 2024. The company also reports negative EBITDA, indicating operational inefficiencies. While gross profit margin improved slightly to 24.71% in 2024, the overall profitability remains weak.
Balance Sheet
25
Negative
The balance sheet reveals significant financial instability, with a negative stockholders' equity of AUD 304.94 million in 2024, indicating potential insolvency risk. The debt-to-equity ratio is not calculable due to negative equity, and the company is highly leveraged with total debt exceeding total assets. Noumi Limited's equity ratio is negative, highlighting a concerning level of liabilities compared to assets.
Cash Flow
35
Negative
The cash flow statement shows some improvement in operating cash flow to AUD 15.83 million in 2024, but free cash flow growth remains volatile. The free cash flow turned positive from a negative position in 2023, suggesting some operational cash generation capability. However, cash flow ratios remain weak due to the negative net income, limiting the assessment of operational efficiency.
BreakdownJun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Income Statement
Total Revenue589.79M551.56M522.34M559.07M580.19M
Gross Profit145.75M133.87M98.42M97.31M2.23M
EBITDA-87.90M-15.39M-130.39M19.35M-134.10M
Net Income-98.33M-46.91M-160.74M-53.18M-174.51M
Balance Sheet
Total Assets316.20M377.95M420.13M538.67M681.90M
Cash, Cash Equivalents and Short-Term Investments21.57M18.56M16.21M31.67M17.17M
Total Debt533.76M491.00M455.01M462.39M486.97M
Total Liabilities621.14M581.49M569.14M537.18M620.90M
Stockholders Equity-304.94M-203.54M-149.01M1.49M61.00M
Cash Flow
Free Cash Flow10.81M-49.00K-46.87M-56.67M-122.71M
Operating Cash Flow15.83M4.31M-40.86M-54.01M-98.68M
Investing Cash Flow1.84M2.22M-3.93M13.50M-28.45M
Financing Cash Flow-21.64M-4.18M29.33M53.80M84.13M

Noumi Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.18
Price Trends
50DMA
0.13
Positive
100DMA
0.14
Positive
200DMA
0.16
Positive
Market Momentum
MACD
<0.01
Negative
RSI
71.07
Negative
STOCH
93.94
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:NOU, the sentiment is Positive. The current price of 0.18 is above the 20-day moving average (MA) of 0.14, above the 50-day MA of 0.13, and above the 200-day MA of 0.16, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 71.07 is Negative, neither overbought nor oversold. The STOCH value of 93.94 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:NOU.

Noumi Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
63
Neutral
$20.97B14.57-8.07%3.14%2.79%-9.97%
40
Underperform
AU$49.88M
4.22%-199.40%
€17.76M-23.00%
€9.23M-240.42%
48
Neutral
AU$24.89M-47.74%43.14%51.35%
AU$5.99M
57
Neutral
AU$33.50M
-5.86%98.26%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AU:NOU
Noumi Limited
0.18
0.04
28.57%
DE:F9H
Australian Dairy Nutritionals Group
0.02
0.01
100.00%
DE:22W0
Wellnex Life Ltd
0.12
-0.36
-75.00%
AU:NUC
Nuchev Pty Ltd
0.16
-0.02
-11.11%
AU:BFC
Beston Global Food Company Ltd
0.01
0.00
0.00%
AU:HCT
Holista Colltech Limited
0.10
0.09
900.00%

Noumi Limited Corporate Events

Noumi Limited Reports Mixed Q4 FY25 Results Amid Legal and Market Challenges
Jul 31, 2025

Noumi Limited reported a slight decline in Q4 FY25 revenue to $155.2 million, with plant-based milks experiencing a 2.9% decrease, while dairy and nutritionals saw a 0.9% increase. Despite a negative operating cash flow of $2.2 million due to legal expenses, the company maintained a positive annual operating cash flow of $32.5 million. Noumi is optimistic about its FY25 earnings, expecting improved operating EBITDA, although it anticipates a net loss after tax due to depreciation, financing costs, and impairment charges. The company continues to see strong performance from its Milklab brand, particularly in retail and export channels, despite competitive pressures and macroeconomic challenges.

The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.

Noumi Limited Resolves Class Action, Paves Way for Future Growth
Jun 25, 2025

Noumi Limited has announced that the Victorian Supreme Court has approved the settlement terms of a class action lawsuit, marking the resolution of a significant legacy issue for the company. With the settlement, which includes Noumi’s $11.56 million contribution covered by insurance, the company can now focus on business growth and enhancing stakeholder value, as it moves past the financial restatements of FY19 and FY20.

The most recent analyst rating on (AU:NOU) stock is a Buy with a A$0.17 price target. To see the full list of analyst forecasts on Noumi Limited stock, see the AU:NOU Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 02, 2025